New Heart Failure Trials

Clinical trials focused on heart failure research, exploring new therapies and treatment strategies. Some of these trials aim to address unmet needs or build upon existing knowledge to improve heart failure management.

EMPEROR-Preserved: This trial investigated the use of empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, in patients with heart failure and preserved ejection fraction (HFpEF). The study assessed the potential benefits of this drug in reducing heart failure hospitalizations and improving cardiovascular outcomes in this specific patient population.

GALACTIC-HF: This global trial evaluated the efficacy and safety of omecamtiv mecarbil, a novel cardiac myosin activator, in patients with heart failure and reduced ejection fraction (HFrEF). The study aimed to determine whether this new therapy could improve cardiac function and reduce heart failure-related events.

VICTORIA: This trial investigated the use of vericiguat, a soluble guanylate cyclase stimulator, in patients with worsening chronic heart failure. The study examined the drug's potential to reduce cardiovascular death and heart failure hospitalization rates.

These trials and others are crucial in advancing the understanding of heart failure and identifying new treatment options that could potentially benefit patients in the future. It's essential to consult the latest scientific literature or clinical trial registries for updates and results.

    Related Conference of New Heart Failure Trials

    May 09-10, 2024

    13th International Conference on Cardiology and Cardiovascular Medicine Research

    Barcelona, Spain
    May 30-31, 2024

    6th Euro Cardiology Congress

    Vienna, Austria
    May 30-31, 2024

    39th World Congress on Heart Diseases

    Vienna, Austria
    June 20-21, 2024

    5th European Summit on Cardiology Research

    Dublin, Ireland
    June 27-28, 2024

    36th World Congress on Cardiology & Heart Diseases

    London, UK
    July 16-17, 2024

    13th World Heart Congress

    Paris, France
    July 18-19, 2024

    32nd International Conference on Cardiology and Cardiovascular Diseases

    Paris, France
    August 01-02, 2024

    38th World Congress on Heart Diseases

    Montreal, Canada
    August 13-14, 2024

    4th World Congress on Congestive Heart Failure & Angina

    Paris, France
    September 16-17, 2024

    3rd Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    September 19-20, 2024

    7th World Heart and Brain Conference

    London, UK
    September 19-20, 2024

    6th Annual Conference on Vascular Medicine

    London, UK
    October 13-14, 2024

    10th International Meet on Cardiology and Heart diseases

    Dubai, UAE
    October 16-17, 2024

    5th Annual Summit on Cardiology and Heart Diseases

    London, UK
    October 17-18, 2024

    28th International Conference on Cardiology and Vascular Imaging

    London, UK
    October 17-18, 2024

    8th Annual Heart Rhythm Conference

    Barcelona, Spain
    October 23-24, 2024

    35th International Conference on Cardiology and Heart Failure

    Paris, France
    October 24-25, 2024

    11th International Conference on Interventional Cardiology

    Zurich, Switzerland
    October 24-25, 2024

    11th International Conference on Geriatric Cardiology, Cardiovascular Diseases and Palliative Care

    Paris, France
    October 30-31, 2024

    7th Global Cardiovascular Research and Clinical Cardiology

    Chicago, USA
    November 13-14, 2024

    12th International Conference on Hypertension and Healthcare

    Dubai, UAE
    November 13-14, 2024

    5th International Conference on Cardiac Imaging and Diagnostics

    Dubai, UAE
    December 21-22, 2024

    34th International Conference onCardiology and Healthcare

    Dubai, UAE

    New Heart Failure Trials Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in